Biography:
Dr. Chandrabose Selvaraj is an Associate professor at Saveetha University. His expertise includes the computational chemistry, Molecular modeling and Drug design. His work is dedicated to understand the molecular level interactions between the Pathogen and humans by applying various theoretical and biophysical methods using Bioinformatics approaches along with few experimental validations. He has published more than 100 publications in peer reviewed Journal(s) including Book chapters and also edited the 2 Books. He is the Editor of various Journals like PLOS One, Frontiers in Immunology, Frontiers in Molecular Biosciences, Frontiers in Microbiology etc. As of Now, He has edited 122 research publications and reviewed 674 publications. Recently, he became the member of Royal Society of Chemistry (MRSc), United Kingdom. He has received 8 awards including the prestigious Marie Skłodowska-Curie Actions award – 2018. He earned numerous fellowships from significant funding organizations to carry out his research.
Education:
ORISE Fellow, NCTR, Food and Drug Administration, USA
Marie Skłodowska-Curie Fellow, Central European Institute of Technology, Czech Republic
Ph.D. Biotechnology, Alagappa University
M.Sc. Bioinformatics, Bharathiar University
B.Sc. Microbiology, Madurai Kamaraj University
Thrust areas:
Drug Designing
Medicinal Chemistry
Data Informatics
Molecular Modelling
Chemoinformatics
Selected Recent Publications:
1) Selvaraj, C*., Dinesh, D. C., Pedone, E. M., Alothaim, A. S., Vijayakumar, R., Rudhra, O., & Singh, S. K. (2023). SARS-CoV-2 ORF8 dimerization and binding mode analysis with class I MHC: computational approaches to identify COVID-19 inhibitors. Briefings in Functional Genomics, elac046. (IF: 4.84)
2) Selvaraj, C*., Ramalingam, K. R., Velmurugan, D., & Singh, S. K. (2023). Transcriptional regulatory mechanisms and signaling networks in cancer. Advances in Protein Chemistry and Structural Biology, 134, 1-20. (IF: 5.27)
3) Kari, S., Murugesan, A., Thiyagarajan, R., Kidambi, S., Razzokov, J., Selvaraj, C*., & Marimuthu, P. (2023). Bias-force guided simulations combined with experimental validations towards GPR17 modulators identification. Biomedicine & Pharmacotherapy, 160, 114320. (IF: 7.41)
4) Sakkiah, S., Singh, B. K., Lee, K. W., & Selvaraj, C*. (2022). Novel Therapeutic Interventions Against Infectious Diseases: COVID-19. Novel Therapeutic Interventions Against Infectious Diseases: COVID-19, 195. (IF: 5.98)
5) Selvaraj, C*., Dinesh, D. C., Krafcikova, P., Boura, E., Aarthy, M., Pravin, M. A., & Singh, S. K. (2022). Structural understanding of SARS-CoV-2 drug targets, active site contour map analysis and COVID-19 therapeutics. Current Molecular Pharmacology, 15(2), 418-433. (IF: 3.855)
6) Selvaraj, C*., Chandra, I., & Singh, S. K. (2022). Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries. Molecular diversity, 1-21. (IF: 3.21)